So why would drug companies push drugs if their power was not all that they claimed? History is part of the market — and perhaps the potential to sell certain drugs once Covid came under control. “More and more drugs such as these are found in India, China, and sub-Saharan Africa, so Pfizer can sell all the other drugs it wants to sell,” said Iyer. “Hospitals can treat patients with cancer, or disease because of all the other drugs they make. And fortunately, it helps a lot. ”
Logically, none of this means that the drug is ineffective. It is possible that, for example, 89 percent of Paxlovid decreases over time. “Once the treatment is given to patients in the hospital as soon as it appears, 10 days of illness, they do not have a serious problem,” said David Boulware, a gynecologist at the University of Minnesota. involved in several Covid drug trials. For one thing, people should get tested for Covid before receiving the drug. “It simply came to our notice then. It’s complicated. Low-income countries are easier to vaccinate. If you can vaccinate people at high risk, then it is a much better hope than trying to deal with illness and treatment. ”
Both drugs have problems with actual use, too. Molnupiravir has been active for 20 years, and has been fighting various infections. Mills says many virus experts have been desperate to find a real job – in part because of the difficulties researchers have seen in years of testing and testing. It will not apply to pregnant women, for example. A recent story mu Number said Merck’s animal trial of molnupiravir found no side effects, and Number quoted Merck’s senior VP as telling investors that the company “believes” in the product’s safety record.
Ritonavir, the second ingredient in the Pfizer package, not only inhibits liver function; it also contains well-known mechanisms and anticoagulants and anticoagulants. Therefore people taking the drug may need to adjust their dosage, or stop taking it for five days of the entire course of study. Not impossible, but not easy, either.
With all that being said, many researchers and medical professionals believe that these new drugs have been effective. Although Mills says he thinks he will be affected, it is still difficult to determine his size. And the total absence of death in the Paxlovid case would be surprising, if the model affects thousands of people. “I have high hopes here,” said Tulio de Olveira, dean of the KwaZulu-Natal Research and Innovation Sequencing Platform at the University of KwaZulu-Natal in South Africa. “Companies, Merck and Pfizer, have issued clear guidelines that the price of these drugs will be significantly lower in developing countries. In addition, they have already begun to cooperate with several local companies to develop their products in developing countries. ”
A large part of the major pharmaceutical companies that are supposed to justify their representation of governments is that the governments may have already seen more than what the companies have openly stated. “They have both trials. They have seen what we have not seen,” says Eric Topol, director of the Scripps Research Translational Institute. has been following vaccination trials and drug development throughout the period, which shows that the unpublished ones look as good as people do.